Medroxyprogesterone 5mg/mL Ophthalmic Solution

Medroxyprogesterone 5mg/mL Ophthalmic Solution is for topical ophthalmic use and is commonly used to treat corneal thinning.

• Volume: 10ml
• Concentration: 5 mg/ml
• We exclusively compound Medroxyprogesterone 5mg/mL Ophthalmic Solution for ophthalmic use only
• Compounded in a sterile compounding facility that is <795>, <797> and <800> chapter compliant

References:

1. O’Brien TP, Li QJ, Sauerburger F, Reviglio VE, Rana T, Ashraf MF. The role of medroxyprogesterone acetate in the treatment of corneal ulceration. Cornea. 1996;15(5):483-489. PMID: 8885931. https://pubmed.ncbi.nlm.nih.gov/8885931/
2. Kenyon KR, Berman M, Rose J, Gage J. Prevention of stromal ulceration in the alkali-burned cornea by medroxyprogesterone. Arch Ophthalmol. 1979;97(9):1733-1737. PMID: 485734. https://pubmed.ncbi.nlm.nih.gov/485734/
3. Berman MB. Regulation of collagenase activity in corneal ulceration. Invest Ophthalmol Vis Sci. 1975;14(10):737-742. PMID: 171166. https://pubmed.ncbi.nlm.nih.gov/171166/
4. Kheirkhah A, Zavareh MK, Farzbod F, Mahbod M, Behrouz MJ. Topical hormonal therapy in ocular surface disease. Ocul Surf. 2016;14(3):379-393. PMID: 27055969. https://pubmed.ncbi.nlm.nih.gov/27055969/